The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 2,076 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ACER THERAPEUTICS INC | Common | 00444P108 | 8,635 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 6,117 | 6,241,581 | SH | SOLE | 6,241,581 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 65,812 | 4,045,000 | SH | SOLE | 4,045,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 112,838 | 9,333,132 | SH | SOLE | 9,333,132 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 57,291 | 755,415 | SH | SOLE | 755,415 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 16,293 | 849,899 | SH | SOLE | 849,899 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 139,122 | 1,963,336 | SH | SOLE | 1,963,336 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 38,939 | 1,048,427 | SH | SOLE | 1,048,427 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | Common | 09060J106 | 15,226 | 5,437,779 | SH | SOLE | 5,437,779 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 132,665 | 1,368,103 | SH | SOLE | 1,368,103 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 16,999 | 4,497,042 | SH | SOLE | 4,497,042 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | Common | 189464100 | 33,677 | 1,146,636 | SH | SOLE | 1,146,636 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | Common | H17182108 | 6,536 | 147,368 | SH | SOLE | 147,368 | 0 | 0 | ||
| DBV TECHNOLOGIES SA | Sponsored ADR | 23306J101 | 1,213 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
| ENDOCYTE INC | Common | 29269A102 | 94,159 | 5,301,718 | SH | SOLE | 5,301,718 | 0 | 0 | ||
| ESTABLISHMENT LABS HOLDINGS INC | Common | G31249108 | 11,448 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 8,386 | 1,022,666 | SH | SOLE | 1,022,666 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 10,925 | 287,500 | SH | SOLE | 287,500 | 0 | 0 | ||
| HORIZON PHARMA PLC | Common | G4617B105 | 87,335 | 4,460,426 | SH | SOLE | 4,460,426 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 368,992 | 17,714,461 | SH | SOLE | 17,714,461 | 0 | 0 | ||
| INTEC PHARMA LTD | Common | M53644106 | 14,524 | 2,570,705 | SH | SOLE | 2,570,705 | 0 | 0 | ||
| INVESCO QQQ TRUST | ETF | 46090E103 | 175 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 97,456 | 8,662,720 | SH | SOLE | 8,662,720 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 99,142 | 463,000 | SH | SOLE | 463,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 225,991 | 4,798,101 | SH | SOLE | 4,798,101 | 0 | 0 | ||
| ONCOBIOLOGICS INC | Common | 68235M105 | 670 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 3 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOSEC MEDICAL INC | Common | 68234L207 | 700 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | Common | 695127100 | 20,309 | 413,196 | SH | SOLE | 413,196 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 2,628 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
| PRINCIPIA BIOPHARMA INC | Common | 74257L108 | 2,192 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | Common | 69366J200 | 32,148 | 684,000 | SH | SOLE | 684,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | Common | 74587V107 | 52,759 | 1,150,685 | SH | SOLE | 1,150,685 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 152,385 | 943,500 | SH | SOLE | 943,500 | 0 | 0 | ||
| SESEN BIO INC | Common | 817763105 | 14,620 | 6,800,000 | SH | SOLE | 6,800,000 | 0 | 0 | ||
| TELIGENT INC | Common | 87960W104 | 20,933 | 5,299,431 | SH | SOLE | 5,299,431 | 0 | 0 | ||
| TESARO INC | Common | 881569107 | 5,852 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | Common | 88322Q108 | 23,520 | 4,200,031 | SH | SOLE | 4,200,031 | 0 | 0 | ||
| TRICIDA INC | Common | 89610F101 | 54,119 | 1,771,500 | SH | SOLE | 1,771,500 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 9,869 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
| SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 130 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 1,050 | 1,250,000 | SH | Put | SOLE | 1,250,000 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 31,247 | 2,367,218 | SH | SOLE | 2,367,218 | 0 | 0 | ||
| Y MABS THERAPEUTICS INC | Common | 984241109 | 8,234 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 72,312 | 1,457,913 | SH | SOLE | 1,457,913 | 0 | 0 | ||